ARK Genomic's market value is the price at which a share of ARK Genomic trades on a public exchange. It measures the collective expectations of ARK Genomic investors about its performance. ARK Genomic is selling for under 4.38 as of the 30th of December 2025; that is 0.68 percent decrease since the beginning of the trading day. The etf's lowest day price was 4.38. With this module, you can estimate the performance of a buy and hold strategy of ARK Genomic and determine expected loss or profit from investing in ARK Genomic over a given investment horizon. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in employment.
Symbol
ARK
ARK Genomic 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ARK Genomic's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ARK Genomic.
0.00
11/30/2025
No Change 0.00
0.0
In 31 days
12/30/2025
0.00
If you would invest 0.00 in ARK Genomic on November 30, 2025 and sell it all today you would earn a total of 0.00 from holding ARK Genomic or generate 0.0% return on investment in ARK Genomic over 30 days.
ARK Genomic Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ARK Genomic's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ARK Genomic upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for ARK Genomic's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ARK Genomic's standard deviation. In reality, there are many statistical measures that can use ARK Genomic historical prices to predict the future ARK Genomic's volatility.
At this stage we consider ARK Etf to be moderately volatile. ARK Genomic secures Sharpe Ratio (or Efficiency) of 0.0271, which signifies that the etf had a 0.0271 % return per unit of return volatility over the last 3 months. We have found thirty technical indicators for ARK Genomic, which you can use to evaluate the volatility of the entity. Please confirm ARK Genomic's Risk Adjusted Performance of 0.0445, semi deviation of 2.49, and Mean Deviation of 2.24 to double-check if the risk estimate we provide is consistent with the expected return of 0.0773%. The etf shows a Beta (market volatility) of 0.57, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ARK Genomic's returns are expected to increase less than the market. However, during the bear market, the loss of holding ARK Genomic is expected to be smaller as well.
Auto-correlation
-0.09
Very weak reverse predictability
ARK Genomic has very weak reverse predictability. Overlapping area represents the amount of predictability between ARK Genomic time series from 30th of November 2025 to 15th of December 2025 and 15th of December 2025 to 30th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ARK Genomic price movement. The serial correlation of -0.09 indicates that less than 9.0% of current ARK Genomic price fluctuation can be explain by its past prices.
Correlation Coefficient
-0.09
Spearman Rank Test
-0.25
Residual Average
0.0
Price Variance
0.0
ARK Genomic lagged returns against current returns
Autocorrelation, which is ARK Genomic etf's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ARK Genomic's etf expected returns. We can calculate the autocorrelation of ARK Genomic returns to help us make a trade decision. For example, suppose you find that ARK Genomic has exhibited high autocorrelation historically, and you observe that the etf is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
ARK Genomic regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ARK Genomic etf is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ARK Genomic etf is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ARK Genomic etf over time.
Current vs Lagged Prices
Timeline
ARK Genomic Lagged Returns
When evaluating ARK Genomic's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ARK Genomic etf have on its future price. ARK Genomic autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ARK Genomic autocorrelation shows the relationship between ARK Genomic etf current value and its past values and can show if there is a momentum factor associated with investing in ARK Genomic.
Regressed Prices
Timeline
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.